Skip to content
The GLP-1 Verdict
Menu
Ranked #272 · Grade C

MyStart Health review

A fast-onboarding compounded GLP-1 service with a genuine dose price-lock, undermined by quiz-gated pricing, unnamed pharmacies and a 2025 FDA warning letter over its marketing.

Visit MyStart Health Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $299/mo (per-drug price quiz-gated)
Tirzepatide
From $299/mo (per-drug price quiz-gated)
Coverage
Multi-state
Brand-name
Compounded only

The scorecard

MyStart Health scored on our six published factors. See the methodology.

Real-world results58/100
Price honesty58/100
Prescriber access80/100
Formulary choice58/100
Cancellation fairness58/100
Member support68/100

What we like

  • The price-lock is stated plainly: 'the price of medication and ongoing care will never increase from your base plan amount, EVEN if your dosage increases in subsequent months'
  • Roughly five-minute intake with a prescription inside 24 hours or a same-day video consultation
  • The $299 base covers physician evaluations, follow-ups, unlimited clinician messaging, medication, any necessary blood work and shipping
  • Publishes a clear Section 503A compounding disclosure stating the medications are not FDA-approved or FDA-evaluated for safety, effectiveness or quality
  • Phone and email support with published weekday and Saturday hours, plus 24/7 care-team access

The caveats

  • FDA warning letter dated 9 September 2025 (MARCS-CMS 714755, addressed to CEO Matthew Stern) found website claims about its compounded semaglutide false or misleading under FDCA sections 502(a) and 502(bb), because they implied the compounded product was the same as an FDA-approved drug
  • Compounded only — no FDA-approved Ozempic, Wegovy, Mounjaro or Zepbound, and no oral route
  • Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality
  • Only the '$299/month, excluding any discounts' floor is published; per-drug plan pricing sits behind the quiz and a signed medical-accuracy attestation, and payment is taken before the clinician review
  • Refund Policy effective 1 December 2025 makes shipped orders strictly non-refundable and non-returnable under any circumstances; pharmacy partners are described only as 'independent third-party pharmacies'

The verdict

Best for: Someone who values speed of onboarding above price transparency and is content to be billed before a clinician has reviewed them. A fast-onboarding compounded GLP-1 service with a genuine dose price-lock, undermined by quiz-gated pricing, unnamed pharmacies and a 2025 FDA warning letter over its marketing.

Ranked #272 of 499 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. On the board it sits between Youth & Soul, 64/100 above and Fresh Day Meds at 63/100 below, with the Trillium Meds ruling the next one down.

A grade C is a ranking, not an instruction to stop looking: the closest rivals to MyStart Health are ruled on the identical rubric, so the comparison is like for like. We have also ruled on it directly: CoreAge Rx vs MyStart Health goes to CoreAge Rx, 94/100 to 63/100.

Visit MyStart Health

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect MyStart Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on MyStart Health's site. Not medical advice; see our disclosure.

← Back to all rankings